Could Coronavirus Be the Turning Point for a 30-Year-Old Technology?

Photo caption: A nurse shows a test for the coronavirus at the Kershaw Mental Health Clinic in Camden, S.C., on Monday, March 23, 2020. Article by Marie Mccullough, The Philadelphia Inquirer/July 1, 2020.

“I think we should set our expectations low. I really think we’re most likely to have several vaccines, and that they will lower disease severity and prevent some infections. It doesn’t have to be 100% effective to have enormous value for the world.”

(TNS) – David B. Weiner is known in scientific circles as “the father of DNA vaccines.” The tag pays homage to his pioneering work over 30 years, but it’s also a reminder that his baby is still aborning.
Not a single human DNA vaccine has made it to market anywhere in the world, and the technology is still rapidly evolving.

The pandemic may be the moment of truth. Genetic code vaccines — built with DNA or RNA — are strong front-runners in the global race to develop an immunization against the coronavirus that has claimed nearly half a million lives worldwide since it emerged in China seven months ago. […]

Click here to view original web page at www.govtech.com

Curated by Theresa Wysocki

See Full Bio